Literature DB >> 35221477

Increasing Diabetes Screening in a Primary Care Setting.

Jennifer J Iyengar1, Mary E K Fisher2, Julie E Ziegler2, Douglas W Wright2, Meghan C Monson3, Cheryl L Rhodes Dehmlow3, Keturah P Schacht4, Jennifer A Wyckoff1, Audrey L Fan5.   

Abstract

Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of Clinical Diabetes. The following article describes an initiative to increase rates of diabetes screening in a large multisite academic health system in the greater Ann Arbor, MI, area.
© 2022 by the American Diabetes Association.

Entities:  

Year:  2022        PMID: 35221477      PMCID: PMC8865780          DOI: 10.2337/cd21-0039

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  3 in total

1.  Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes.

Authors:  Matthew J O'Brien; Kai McKeever Bullard; Yan Zhang; Edward W Gregg; Mercedes R Carnethon; Namratha R Kandula; Ronald T Ackermann
Journal:  J Gen Intern Med       Date:  2018-04-12       Impact factor: 5.128

Review 2.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

3.  Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.

Authors:  Matthew J O'Brien; Ji Young Lee; Mercedes R Carnethon; Ronald T Ackermann; Maria C Vargas; Andrew Hamilton; Nivedita Mohanty; Sarah S Rittner; Jessica N Park; Amro Hassan; David R Buchanan; Lei Liu; Joseph Feinglass
Journal:  PLoS Med       Date:  2016-07-12       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.